UBS Reiterates Buy Rating on Boston Scientific (BSX)

1 week ago 6

Boston Scientific Corporation (NYSE:BSX) is 1 of the 14 Best Large Cap Stocks to Invest In Now. On December 17, UBS reiterated its Buy standing connected Boston Scientific Corporation (NYSE:BSX) and kept the terms people astatine $140. This update comes adjacent arsenic the shares experienced a driblet implicit the past month.

UBS expert Danielle Antalffy believes that the risk/reward illustration for Boston Scientific Corporation (NYSE:BSX) is “increasingly skewed to the upside” heading into 2026. This presumption is supported by the firm’s sentiment that high-growth concern areas volition beryllium capable to prolong the caller momentum.

UBS Reiterates Buy Rating connected  Boston Scientific (BSX)

UBS Reiterates Buy Rating connected Boston Scientific (BSX)

According to UBS, the company’s Electrophysiology (EP) division, which makes up astir 17% of the company’s 2025 estimated sales, is expected to dilatory successful 2026. However, the probe steadfast pointed retired that Boston Scientific Corporation’s (NYSE:BSX) CEO Mike Mahoney is committed to increasing this part higher than marketplace rates, estimated astatine 20-25%.

The company’s CEO has besides voiced a steadfast content successful sustained double-digit maturation for the WATCHMAN device, which represents astir 10% of estimated income successful 2025. Mahoney is assured astir this adjacent earlier the upcoming CHAMPION information readout, which is expected successful outpouring 2026.

UBS thinks Boston Scientific Corporation (NYSE:BSX) is successful a bully presumption to usher 2026 income maturation higher than its long-range people of 10-12%. This imaginable upside successful 2026 is expected to travel chiefly from the WATCHMAN business.

Boston Scientific Corporation (NYSE:BSX) is an American biotechnology and biomedical engineering institution that offers a portfolio of devices and therapies that assistance physicians diagnose and dainty cardiovascular, respiratory, digestive, oncological, neurological, and urological diseases and conditions.

While we admit the imaginable of BSX arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you’re looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 14 Most Promising Fintech Stocks to Invest In and 15 Best Technology Penny Stocks to Buy.

Disclosure: None. This nonfiction is primitively published astatine Insider Monkey.

Read Entire Article